Literature DB >> 21188629

The association between two polymorphisms in the TYMS gene and breast cancer risk: a meta-analysis.

Jun Wang1, Baocheng Wang, Jingwang Bi, Jianshi Di.   

Abstract

Thymidylate synthase (TYMS), which catalyzes the conversion of deoxyuridine monophosphate to deoxythymidine monophosphate, is a central enzyme in the folate metabolic pathway. Epidemiological studies have evaluated the association between TYMS gene polymorphisms and breast cancer susceptibility; however, the published data are still inconclusive. To derive a more precise assessment of this relationship, we performed a meta-analysis based on currently available data by searching PubMed, EMBASE databases, and the Cochrane Library. A total of 10 eligible studies were identified for the TYMS TSER polymorphism (six studies with 2,718 cases and 3,423 controls) and for the TYMS TS3'-UTR polymorphism (five studies with 1,969 cases and 2,290 controls). The overall odds ratio (OR) and the corresponding 95% confidence interval (CI) showed a statistical association between the TSER polymorphism and breast cancer risk under homozygote comparison (2R/2R vs. non-2R/non-2R; OR 1.25; 95% CI 1.04-1.50), allele contrast (2R vs. non-2R; OR 1.09; 95% CI 1.01-1.19) and the recessive model (OR 1.19; 95% CI 1.01-1.39). In the subgroup analysis by ethnicity, a statistically significant increase in cancer risk was found among Caucasians for homozygote comparison (OR 1.31; 95% CI 1.10-1.57), the allele contrast model (OR 1.12; 95% CI 1.02-1.23) and the dominant model (OR 1.40; 95% CI 1.00-1.95). For the TS3'-UTR polymorphism, significant effects were shown using the allele contrast model (OR 1.33; 95% CI 1.03-1.73). However, the TS3'-UTR polymorphism increased breast cancer risk among Asian women (del6 vs. ins6; OR 1.41; 95% CI 1.01-1.98) but not Caucasian women using the homozygote comparison. In conclusion, our meta-analysis suggests that the TSER polymorphism may increase susceptibility to breast cancer in the Caucasian population and the TS3'-UTR polymorphism may be a genetic determinant for developing breast cancer in the Asian population; therefore, ethnic background should be carefully considered in further studies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21188629     DOI: 10.1007/s10549-010-1314-0

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  13 in total

1.  Folate metabolism-related gene polymorphisms and susceptibility to primary liver cancer in North China.

Authors:  Lian-Hua Cui; Yang Song; Hongzong Si; Fangzhen Shen; Min-Ho Shin; Hee Nam Kim; Jin-Su Choi
Journal:  Med Oncol       Date:  2011-09-29       Impact factor: 3.064

2.  Relationships among folate, alcohol consumption, gene variants in one-carbon metabolism and p16INK4a methylation and expression in healthy breast tissues.

Authors:  Adana A Llanos; Ramona G Dumitrescu; Theodore M Brasky; Zhenhua Liu; Joel B Mason; Catalin Marian; Kepher H Makambi; Scott L Spear; Bhaskar V S Kallakury; Jo L Freudenheim; Peter G Shields
Journal:  Carcinogenesis       Date:  2014-10-24       Impact factor: 4.944

Review 3.  Targeting nuclear thymidylate biosynthesis.

Authors:  James Chon; Patrick J Stover; Martha S Field
Journal:  Mol Aspects Med       Date:  2016-11-19

4.  Population-level diversity in the association of genetic polymorphisms of one-carbon metabolism with breast cancer risk.

Authors:  Shaik Mohammad Naushad; Chandrasekhar Divya; M Janaki Ramaiah; Tajamul Hussain; Salman A Alrokayan; Vijay Kumar Kutala
Journal:  J Community Genet       Date:  2016-08-19

5.  Genetic variant rs16430 6bp > 0bp at the microRNA-binding site in TYMS and risk of sporadic breast cancer risk in non-Hispanic white women aged ≤ 55 years.

Authors:  Xiaoxiang Guan; Hongliang Liu; Jingfang Ju; Yangkai Li; Peng Li; Li-E Wang; Abenaa M Brewster; Thomas A Buchholz; Banu K Arun; Qingyi Wei; Zhensheng Liu
Journal:  Mol Carcinog       Date:  2013-10-26       Impact factor: 4.784

6.  Molecular portrait of breast cancer in China reveals comprehensive transcriptomic likeness to Caucasian breast cancer and low prevalence of luminal A subtype.

Authors:  Xiaoyan Huang; Matteo Dugo; Maurizio Callari; Marco Sandri; Loris De Cecco; Barbara Valeri; Maria Luisa Carcangiu; Jingyan Xue; Rui Bi; Silvia Veneroni; Maria Grazia Daidone; Sylvie Ménard; Elda Tagliabue; Zhimin Shao; Jiong Wu; Rosaria Orlandi
Journal:  Cancer Med       Date:  2015-03-18       Impact factor: 4.452

Review 7.  Ethnic background and genetic variation in the evaluation of cancer risk: a systematic review.

Authors:  Lijun Jing; Li Su; Brian Z Ring
Journal:  PLoS One       Date:  2014-06-05       Impact factor: 3.240

8.  TSER polymorphism is not associated with risk of pediatric acute lymphoblastic leukemia: A meta-analysis.

Authors:  Zhaohua Qiao; Dan Lou; Li Ruan
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

9.  Thymidylate synthase gene (TYMS) polymorphisms in sporadic and hereditary breast cancer.

Authors:  José da Silva Nogueira; Fernando Augusto de Lima Marson; Carmen Sílvia Bertuzzo
Journal:  BMC Res Notes       Date:  2012-12-06

10.  3'UTR polymorphism of Thymidylate Synthase gene increased the risk of persistence of pre-neoplastic cervical lesions.

Authors:  Nayara Nascimento Toledo Silva; Ana Carolina Silva Santos; Verlândia Mendes Nogueira; Cláudia Martins Carneiro; Angélica Alves Lima
Journal:  BMC Cancer       Date:  2020-04-15       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.